3 COVID Stocks Ready to Take On the Delta Variant
We're still fighting COVID-19, and as we approach winter the number of infections and hospitalizations might increase. Of course the best thing to do is to vaccinate. We know that COVID is mutating, like the flu, but at a much slower rate than the flu.
According to the Centers for Disease Control and Prevention (CDC), the delta variant is by far the most common COVID variant, making up 99% of new cases. And of course the vaccines were developed to stop the original strain of the coronavirus. Will the vaccines work against delta? And what stocks should we buy to "immunize" our ports? Our trio of Fools suggest you might want to take a jab of Novavax (NASDAQ: NVAX), Pfizer (NYSE: PFE) and Eli Lilly (NYSE: LLY).
Image source: Getty Images.
Source Fool.com
